Related Experiment Video
Updated: Aug 16, 2025

06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
12.6K
Cutaneous Basal Cell Carcinoma: Does Noninvasive Ventilation Accelerate Tumor Progression?
Antonella Tammaro1, Ganiyat Adenike Ralitsa Adebanjo2, Aldo Pezzuto3
1Dermatology Department, NESMOS, Sapienza University of Rome, Rome, Italy; antonella.tammaro@uniroma1.it.
Skinmed
|December 20, 2022
Summary
Noninvasive ventilation for COVID-19 may worsen basal cell carcinoma. This treatment for coronavirus disease 2019 in COPD patients showed a dramatic progression of skin cancer lesions.
Area of Science:
- Dermatology and Respiratory Medicine
- Oncology and Infectious Diseases
Background:
- A 56-year-old female patient with chronic obstructive pulmonary disease (COPD) presented with symptoms including diarrhea, asthenia, cough, and dysgeusia.
- The patient was diagnosed with coronavirus disease 2019 (COVID-19).
Observation:
- A small basal cell carcinoma (BCC) lesion was incidentally discovered on the patient's scalp during examination.
- Following the initiation of noninvasive ventilation for COVID-19 management, a significant worsening of the BCC lesion was observed, both macroscopically and microscopically.
Findings:
- The study suggests a potential link between positive pressure noninvasive ventilation and the accelerated progression of cutaneous basal cell carcinoma.
- The observed BCC exacerbation occurred in the context of treating COVID-19 in a patient with underlying COPD.
Implications:
- Clinicians should consider the potential dermatological side effects of noninvasive ventilation, particularly in patients with pre-existing skin conditions like BCC.
- Further research is warranted to elucidate the mechanisms by which positive pressure ventilation may influence the behavior of cutaneous malignancies.
More Related Videos
Related Concept Videos
Skin Cancer
4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)